AQP2 and heart failure: Lütken confirmed that AT1 receptor inhibitor cambishtan could reduce the expression of AQP-2 in kidneys of mice with heart failure [21], suggesting that RAS may play a role in regulating the expression of AQP-2 in kidneys of mice.